January 16, 2017 1:42 PM ET

Biotechnology

Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.25 RelationshipsChief Executive Officer, President and Director61
Arthur G. Altschul Jr.39 RelationshipsCo-Founder and Chairman of the Board51
Joseph P. Schlessinger Ph.D.70 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director71
Ronald A. Peck M.D.No RelationshipsChief Medical Officer and Senior Vice President of Clinical Development--
Yaron Hadari Ph.D.No RelationshipsVice President of Research--

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 39 RelationshipsDiaz & Altschul Group LLC51
Gerald McMahon Ph.D. 25 RelationshipsKolltan Pharmaceuticals, Inc.61
Axel Bolte M.Sc., M.B.A. 34 RelationshipsHBM Partners Ltd.44
Joseph P. Schlessinger Ph.D. 70 RelationshipsPlexxikon Inc.71
K. Peter Hirth Ph.D. 94 RelationshipsTrovaGene, Inc.64
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger70 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$400.0K
400.0K
370.9K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
400.0K
34.4M
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

InMed Pharmaceuticals Inc. Appoints Martin Bott to the Board of Directors
January 13, 2017 8:42 PM ET
Uni-Bio Science Group Limited Announces Executive Changes
January 13, 2017 11:38 AM ET
Bioscience Americas, LLC Appoints Shekhar K. Challa to Its Board of Advisors
January 13, 2017 11:30 AM ET
Nivalis Therapeutics, Inc. Announces Management Changes, with Effect from January 15, 2017
January 12, 2017 9:16 PM ET
Immunomedics, Inc. Announces Board Changes
January 12, 2017 9:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.